What kind of medicine is Semaglutide tablets and how much does it cost?

Semaglutide tablets (Rybelsus) can be used to treat adult patients with poorly controlled type 2 diabetes to help them stabilize blood sugar levels. If metformin is not suitable, semaglutide tablets can be taken alone or in combination with other medications to treat diabetes, but must be combined with a balanced diet and regular physical exercise.

The starting dose of semaglutide tablets is 3 mg once daily for one month. After one month, the dose should be increased to a maintenance dose of 7 mg once daily. After at least one month of a once-daily dose of 7 mg, the dose may be increased to a once-daily maintenance dose of 14 mg to further improve glycemic control.

The maximum recommended daily dose of semaglutide tablets is 14 mg. Taking two 7 mg tablets to achieve a 14 mg dose has not been studied and is not recommended.

Semaglutide is a GLP-1 analogue with 94% sequence homology to human GLP-1. Semaglutide acts as a GLP-1 receptor agonist and selectively binds to and activates the GLP-1 receptor, the target of natural GLP-1.

GLP-1 is a physiological hormone with multiple roles in glucose and appetite regulation as well as in the cardiovascular system. The effects of glucose and appetite are mediated exclusively through GLP-1 receptors in the pancreas and brain.

When blood glucose is high, semaglutide lowers blood glucose in a glucose-dependent manner by stimulating insulin secretion and decreasing glucagon secretion. The mechanism of hypoglycemia also involves a slight delay in early postprandial gastric emptying. During hypoglycemia, semaglutide reduces insulin secretion but does not impair glucagon secretion. The mechanism of action of semaglutide is independent of the route of administration.

Semaglutide reduces body weight and body fat mass by reducing energy intake, thereby reducing overall appetite. Additionally, semaglutide reduces the preference for high-fat foods.

GLP-1 receptors are expressed in the heart, vasculature, immune system, and kidneys. Clinical studies have shown that semaglutide has beneficial effects on blood lipids, lowering systolic blood pressure and reducing inflammation. In animal studies, semaglutide attenuated the development of atherosclerosis by preventing aortic plaque progression and reducing inflammation in the plaques.

This year, semaglutide tablets have just entered the domestic market, but the supply of the new drug may be unstable in the early stage, making it difficult for patients to purchase it. We can first explore the situation of semaglutide tablets in overseas markets. It is reported that the price of the overseas version of 3mg*100 tablets of oral semaglutide is about 2,000 yuan. Moreover, this drug is available in various other specifications on the overseas market. If you have more questions about oral semaglutide, it is recommended to seek answers from regular overseas medical consultants.